Silvânia Maria Andrade Cerqueira

Silvânia Maria Andrade Cerqueira

Auto-generated profile, based on publicly available information

Silvânia Maria Andrade Cerqueira

Laboratory of Immunology and Molecular Biology of the Health Sciences Institute of the Federal University of Bahia, Bahia, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
MCMarilda Casela
Marilda Casela
SCSilvânia Maria Andrade Cerqueira
Silvânia Maria Andrade Cerqueira
TCThais de Oliveira Casela
Thais de Oliveira Casela
MPMariana Pereira
Mariana Pereira
SSSamanta Queiroz dos Santos
Samanta Queiroz dos Santos
EMEliana Dias Matos
Eliana Dias Matos
Objective: To evaluate the impact of the use of the molecular test for Mycobacterium tuberculosis and its resistance to rifampin (Xpert MTB/RIF), under routine conditions, at a referral hospital in the Brazilian state of Bahia. Methods: This was a descriptive study using the database of the Mycobacteriology Laboratory of the Octávio Mangabeira Specialized Hospital, in the city of Salvador, and georeferencing software. We evaluated 3,877 sputum samples collected from symptomatic respiratory patients, under routine conditions, between June of 2014 and March of 2015. All of the samples were submitted to sputum smear microscopy and the Xpert MTB/RIF test. Patients were stratified by gender, age, and geolocation. Results: Among the 3,877 sputum samples evaluated, the Xpert MTB/RIF test detected M. tuberculosis in 678 (17.5%), of which 60 (8.8%) showed resistance to rifampin. The Xpert MTB/RIF test detected M. tuberculosis in 254 patients who tested negative for sputum smear microscopy, thus increasing the diagnostic power by 59.9%. Conclusions: The use of the Xpert MTB/RIF test, under routine conditions, significantly increased the detection of cases of tuberculosis among sputum smear-negative patients.